$0.60 31.4%
EGRX Stock Price vs. AI Score
Data gathered: October 14

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Eagle Pharmaceuticals

Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and marketing injectable products primarily in the areas of metabolic critical care and oncology in the United States. The company is headquartered in Woodcliff Lake, New Jersey.


Eagle Pharmaceuticals
Price $0.60
Target Price Sign up
Volume 9,400
Market Cap $11M
Year Range $0.55 - $6.51
Dividend Yield 0%
PE Ratio 0.98
Analyst Rating 0% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '2363M50M13M5.2M16M1.180
Q1 '2365M51M14M5.8M17M1.260
Q4 '2266M50M17M8.2M21M1.100
Q3 '2265M51M14M-7.1M1.2M1.120
Q2 '2274M62M12M-9.5M-3.8M1.560

Insider Transactions View All

Tarriff Scott filed to sell 545,447 shares at $13.9.
November 3 '23
Tarriff Scott filed to sell 556,141 shares at $13.8.
November 3 '23
Tarriff Scott filed to sell 567,066 shares at $15.1.
October 4 '23
Tarriff Scott filed to sell 567,776 shares at $14.4.
October 4 '23
Tarriff Scott filed to sell 577,800 shares at $15.2.
October 4 '23

What is the Market Cap of Eagle Pharmaceuticals?

The Market Cap of Eagle Pharmaceuticals is $11M.

What is Eagle Pharmaceuticals' PE Ratio?

As of today, Eagle Pharmaceuticals' PE (Price to Earnings) ratio is 0.98.

What is the current stock price of Eagle Pharmaceuticals?

Currently, the price of one share of Eagle Pharmaceuticals stock is $0.60.

How can I analyze the EGRX stock price chart for investment decisions?

The EGRX stock price chart above provides a comprehensive visual representation of Eagle Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eagle Pharmaceuticals shares. Our platform offers an up-to-date EGRX stock price chart, along with technical data analysis and alternative data insights.

Does EGRX offer dividends to its shareholders?

As of our latest update, Eagle Pharmaceuticals (EGRX) does not offer dividends to its shareholders. Investors interested in Eagle Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Eagle Pharmaceuticals?

Some of the similar stocks of Eagle Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.